2. Lynch HT, Lynch P, Lanspa S, Snyder C, Lynch J, Boland C. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76(1):1-18. [
DOI:10.1111/j.1399-0004.2009.01230.x] [
PMID] [
PMCID]
3. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. The New England journal of medicine. 2003;348(10):919-32. [
DOI:10.1056/NEJMra012242] [
PMID]
4. Siraj AK, Prabhakaran S, Bavi P, Bu R, Beg S, Hazmi MA, et al. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer. 2015;121(11):1762-71. [
DOI:10.1002/cncr.29288] [
PMID]
5. King M-C, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643-6. [
DOI:10.1126/science.1088759] [
PMID]
6. Umar A, Boland CR, Terdiman JP, Syngal S, Chapelle Adl, Rüschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4):261-8. [
DOI:10.1093/jnci/djh034] [
PMID] [
PMCID]
7. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11(1):42. [
DOI:10.1097/GIM.0b013e31818fa2db] [
PMID] [
PMCID]
8. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, et al. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105(3):569-74. [
DOI:10.1097/01.AOG.0000154885.44002.ae] [
PMID]
9. Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? J Clin Oncol. 2005;23(36):9344-50. [
DOI:10.1200/JCO.2005.03.5915] [
PMID]
10. Bengtsson D, Joost P, Aravidis C, Askmalm Stenmark M, Backman AS, Melin B, et al. Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort. The Journal of clinical endocrinology and metabolism. 2017;102(11):3928-32. [
DOI:10.1210/jc.2017-01401] [
PMID]
11. Lu Y, Milchgrub S, Khatri G, Gopal P. Metachronous Uterine Endometrioid Adenocarcinoma and Peritoneal Mesothelioma in Lynch Syndrome: A Case Report. International journal of surgical pathology. 2017;25(3):253-7. [
DOI:10.1177/1066896916680745] [
PMID]
12. Pelizzo MR, Pennelli G, Zane M, Galuppini F, Colletti PM, Merante Boschin I, et al. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2015;74:9-16. [
DOI:10.1016/j.biopha.2015.06.008] [
PMID]
13. Pugalenthi A, Bradley C, Gonen M, Do KG, Strong V, Jarnagin W, et al. Splenectomy to treat splenic lesions: an analysis of 148 cases at a cancer center. Journal of surgical oncology. 2013;108(8):521-5. [
DOI:10.1002/jso.23433] [
PMID]
14. Comperat E, Bardier-Dupas A, Camparo P, Capron F, Charlotte F. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Archives of pathology & laboratory medicine. 2007;131(6):965-9. [
DOI:10.5858/2007-131-965-SMCPDD] [
PMID]